Maravai LifeSciences Holdings (MRVI) Stock Forecast — 2-Week Outlook

StockMap's current 2-week read on Maravai LifeSciences Holdings (MRVI) is Neutral.

The composite score behind that read is +0.08, weighing +0.18 of bullish evidence against -0.14 bearish.

Maravai LifeSciences Holdings last closed at $7.44, +3.19% on the session.

Against the IVW growth benchmark the position is +2.39% over the forecast window.

The read is built from 15 underlying insights — 5 bullish and 10 bearish.

Agreement across those insights is 67%.

Maravai LifeSciences Holdings has no graded predictions yet. We publish our accuracy across thousands of stocks in the open, misses included.

On the fundamentals StockMap ranks Maravai LifeSciences Holdings in the 22nd percentile on return on equity, where 100 is best.

Maravai LifeSciences Holdings is classified under Health Care / Life Sciences Tools & Services, with a market capitalisation of $1.87B.

StockMap tracks Maravai LifeSciences Holdings as the 26th largest of the 41 companies it covers in the Life Sciences Tools & Services industry, part of the Health Care sector.

Across that group the current two-week reads are 37 Neutral, 2 Moderate Outperform and 2 Moderate Underperform.

On that composite Maravai LifeSciences Holdings ranks 15th of 41 in the group, against a group median of +0.06.